Published in EMBO J on January 01, 1983
Compilation of published signal sequences. Nucleic Acids Res (1984) 11.33
Mechanisms of protein localization. Microbiol Rev (1983) 6.12
In vitro translocation of bacterial proteins across the plasma membrane of Escherichia coli. Proc Natl Acad Sci U S A (1984) 2.46
Analysis of the distribution of charged residues in the N-terminal region of signal sequences: implications for protein export in prokaryotic and eukaryotic cells. EMBO J (1984) 2.43
Effects of signal sequence mutations on the kinetics of alkaline phosphatase export to the periplasm in Escherichia coli. J Bacteriol (1986) 2.17
Alteration of the amino terminus of the mature sequence of a periplasmic protein can severely affect protein export in Escherichia coli. Proc Natl Acad Sci U S A (1988) 1.96
Secretion-defective mutations in the signal sequence for Saccharomyces cerevisiae invertase. Mol Cell Biol (1986) 1.66
Analysis of mutational alterations in the hydrophilic segment of the maltose-binding protein signal peptide. J Bacteriol (1989) 1.25
Translational control of exported proteins that results from OmpC porin overexpression. J Bacteriol (1988) 1.24
Nucleotide sequence and transcriptional analysis of the E. coli ushA gene, encoding periplasmic UDP-sugar hydrolase (5'-nucleotidase): regulation of the ushA gene, and the signal sequence of its encoded protein product. Nucleic Acids Res (1986) 1.22
Requirement of heat-labile cytoplasmic protein factors for posttranslational translocation of OmpA protein precursors into Escherichia coli membrane vesicles. J Bacteriol (1988) 1.20
Mutation prlF1 relieves the lethality associated with export of beta-galactosidase hybrid proteins in Escherichia coli. J Bacteriol (1984) 1.17
Cloning and expression in Escherichia coli of the regulatory sacU gene from Bacillus subtilis. J Bacteriol (1985) 1.14
Does secA mediate coupling between secretion and translation in Escherichia coli? J Bacteriol (1986) 1.06
Association of degradation and secretion of three chimeric polypeptides in Escherichia coli. J Bacteriol (1988) 1.03
Mutations affecting the signal sequence alter synthesis and secretion of yeast invertase. Proc Natl Acad Sci U S A (1986) 0.95
Evaluation of a novel subtilisin inhibitor gene and mutant derivatives for the expression and secretion of mouse tumor necrosis factor alpha by Streptomyces lividans. Appl Environ Microbiol (1997) 0.93
Translational control of exported proteins in Escherichia coli. J Bacteriol (1986) 0.92
Effect of OmpA signal peptide mutations on OmpA secretion, synthesis, and assembly. J Bacteriol (1991) 0.88
Cassette mutagenic analysis of the yeast invertase signal peptide: effects on protein translocation. Mol Cell Biol (1989) 0.86
Signal sequence mutations that alter coupling of secretion and translation of an Escherichia coli outer membrane protein. J Bacteriol (1987) 0.85
Cloning and expression in Escherichia coli of three fragments of diphtheria toxin truncated within fragment B. J Bacteriol (1987) 0.84
Alterations in the hydrophilic segment of the maltose-binding protein (MBP) signal peptide that affect either export or translation of MBP. J Bacteriol (1992) 0.82
Synthesis of an Escherichia coli protein carrying a signal peptide mutation causes depolarization of the cytoplasmic membrane potential. J Bacteriol (1988) 0.80
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J Cell Biol (1975) 36.95
A possible precursor of immunoglobulin light chains. Nat New Biol (1972) 11.03
Translocation of proteins across the endoplasmic reticulum III. Signal recognition protein (SRP) causes signal sequence-dependent and site-specific arrest of chain elongation that is released by microsomal membranes. J Cell Biol (1981) 8.36
The outer membrane proteins of Gram-negative bacteria: biosynthesis, assembly, and functions. Annu Rev Biochem (1978) 7.96
E. coli mutant pleiotropically defective in the export of secreted proteins. Cell (1981) 7.72
Isolation of the bacteriophage lambda receptor from Escherichia coli. J Bacteriol (1973) 7.67
Secretory protein translocation across membranes-the role of the "docking protein'. Nature (1982) 7.23
Use of gene fusion to study secretion of maltose-binding protein into Escherichia coli periplasm. J Bacteriol (1979) 6.38
Suppressor mutations that restore export of a protein with a defective signal sequence. Cell (1981) 6.33
Regulation of a membrane component required for protein secretion in Escherichia coli. Cell (1982) 5.70
Maltose transport in Escherichia coli K-12: involvement of the bacteriophage lambda receptor. J Bacteriol (1975) 5.68
Secretion and membrane localization of proteins in Escherichia coli. CRC Crit Rev Biochem (1980) 5.57
Transfer of proteins across membranes. Annu Rev Biochem (1981) 5.55
Genetic analysis of the major outer membrane proteins of Escherichia coli. Annu Rev Genet (1981) 5.30
A role for mRNA secondary structure in the control of translation initiation. Nature (1982) 5.01
Mutations which alter the function of the signal sequence of the maltose binding protein of Escherichia coli. Nature (1980) 4.77
Use of gene fusions to study outer membrane protein localization in Escherichia coli. Proc Natl Acad Sci U S A (1977) 3.78
Mutations affecting localization of an Escherichia coli outer membrane protein, the bacteriophage lambda receptor. J Mol Biol (1980) 3.62
Escherichia coli mutants impaired in maltodextrin transport. J Bacteriol (1979) 3.51
Role of positive charge on the amino-terminal region of the signal peptide in protein secretion across the membrane. Proc Natl Acad Sci U S A (1982) 3.44
Sequence analysis of mutations that prevent export of lambda receptor, an Escherichia coli outer membrane protein. Nature (1980) 3.36
Structure of the malB region in Escherichia coli K12. I. Genetic map of the malK-lamB operon. Mol Gen Genet (1979) 2.99
Localization and processing of outer membrane and periplasmic proteins in Escherichia coli strains harboring export-specific suppressor mutations. J Biol Chem (1982) 2.85
Mutations that affect lamB gene expression at a posttranscriptional level. Proc Natl Acad Sci U S A (1981) 2.46
Mutations altering the cellular localization of the phage lambda receptor, an Escherichia coli outer membrane protein. Proc Natl Acad Sci U S A (1978) 2.37
Pattern of protein synthesis in monkey cells infected by simian virus 40. J Virol (1972) 2.35
Sequence information within the lamB genes in required for proper routing of the bacteriophage lambda receptor protein to the outer membrane of Escherichia coli K-12. J Mol Biol (1982) 2.20
Protein Ia and the lamB protein can replace each other in the constitution of an active receptor for the same coliphage. Proc Natl Acad Sci U S A (1978) 2.06
A signal sequence is not sufficient to lead beta-galactosidase out of the cytoplasm. Nature (1980) 2.00
Diverse effects of mutations in the signal sequence on the secretion of beta-lactamase in Salmonella typhimurium. Cell (1982) 1.86
Interaction of bacteriophage K10 with its receptor, the lamB protein of Escherichia coli. J Bacteriol (1979) 1.59
Role of the mature protein sequence of maltose-binding protein in its secretion across the E. coli cytoplasmic membrane. Cell (1981) 1.51
Monoclonal antibody as a probe for structure and function of an Escherichia coli outer membrane protein. J Biol Chem (1982) 1.34
Reconsidering the early steps of protein secretion. Ann Microbiol (Paris) (1982) 1.00
Regulation of intracellular protein traffic. Cold Spring Harb Symp Quant Biol (1982) 0.78
The UCSC Genome Browser Database. Nucleic Acids Res (2003) 32.84
Regulation of tumor antigen synthesis by simain virus 40 gene A. J Virol (1975) 9.93
Positive control of transcription initiation in bacteria. Annu Rev Genet (1984) 8.74
Isolation of the bacteriophage lambda receptor from Escherichia coli. J Bacteriol (1973) 7.67
Location of the maltose A and B loci on the genetic map of Escherichia coli. J Bacteriol (1966) 5.97
Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med (2001) 5.48
Maltose transport in Escherichia coli K12. A comparison of transport kinetics in wild-type and lambda-resistant mutants as measured by fluorescence quenching. Eur J Biochem (1976) 5.25
A role for mRNA secondary structure in the control of translation initiation. Nature (1982) 5.01
Use of gene fusions to study outer membrane protein localization in Escherichia coli. Proc Natl Acad Sci U S A (1977) 3.78
The adsorption of coliphage lambda to its host: effect of variations in the surface density of receptor and in phage-receptor affinity. J Mol Biol (1976) 3.75
Genetic analysis of the maltose A region in Escherichia coli. J Bacteriol (1969) 3.52
Escherichia coli mutants impaired in maltodextrin transport. J Bacteriol (1979) 3.51
Dominant constitutive mutations in malT, the positive regulator gene of the maltose regulon in Escherichia coli. J Mol Biol (1978) 3.46
Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation. Lancet (1991) 3.37
[Existence in Escherichia coli K 12 of a common regulation of the biosynthesis of bacteriophage receptors and maltose metabolism]. Ann Inst Pasteur (Paris) (1967) 3.33
Pleiotropic mutations rendering Escherichia coli K-12 resistant to bacteriophage TP1. J Bacteriol (1980) 3.31
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med (1999) 3.13
Patterns of polymorphism and linkage disequilibrium for cystic fibrosis. Genomics (1987) 3.03
Coronary artery bypass grafting: the Society of Thoracic Surgeons National Database experience. Ann Thorac Surg (1994) 3.00
Structure of the malB region in Escherichia coli K12. I. Genetic map of the malK-lamB operon. Mol Gen Genet (1979) 2.99
[Phenotypic expression and genetic localization of mutations affecting maltose metabolism in Escherichia coli K 12]. Ann Inst Pasteur (Paris) (1967) 2.83
Structure of the malB region in Escherichia coli K12. II. Genetic map of the malE,F,G operon. Mol Gen Genet (1979) 2.83
Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet (2001) 2.70
Complementation studies in the maltose-A region of the Escherichia coli K12 genetic map. J Mol Biol (1971) 2.60
malB region in Escherichia coli K-12: characterization of new mutations. J Bacteriol (1974) 2.56
CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet (2001) 2.51
Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer. J Clin Oncol (1993) 2.49
Intergration of the receptor for bacteriophage lambda in the outer membrane of Escherichia coli: coupling with cell division. J Bacteriol (1975) 2.47
Mutations that affect lamB gene expression at a posttranscriptional level. Proc Natl Acad Sci U S A (1981) 2.46
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Mutations altering the cellular localization of the phage lambda receptor, an Escherichia coli outer membrane protein. Proc Natl Acad Sci U S A (1978) 2.37
Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics. Hum Genet (1990) 2.33
Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med (1998) 2.31
The use of gene fusions to study the expression of malT the positive regulator gene of the maltose regulon. J Mol Biol (1979) 2.27
Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest (1999) 2.24
Control of expression of the pyr genes in Salmonella typhimurium: effects of variations in uridine and cytidine nucleotide pools. J Bacteriol (1975) 2.24
[Maltodextrin phosphorylase of Escherichia coli]. Eur J Biochem (1967) 2.21
Sequence information within the lamB genes in required for proper routing of the bacteriophage lambda receptor protein to the outer membrane of Escherichia coli K-12. J Mol Biol (1982) 2.20
A technique for integrating any DNA fragment into the chromosome of Escherichia coli. Gene (1984) 2.11
Phosphoglucomutase mutants of Escherichia coli K-12. J Bacteriol (1971) 2.07
The enigma of myelin-associated growth inhibitors in spontaneously regenerating nervous systems. Trends Neurosci (1994) 2.06
Protein Ia and the lamB protein can replace each other in the constitution of an active receptor for the same coliphage. Proc Natl Acad Sci U S A (1978) 2.06
Colicin E2 release: lysis, leakage or secretion? Possible role of a phospholipase. EMBO J (1984) 2.02
Extracellular pullulanase of Klebsiella pneumoniae is a lipoprotein. J Bacteriol (1986) 2.02
A signal sequence is not sufficient to lead beta-galactosidase out of the cytoplasm. Nature (1980) 2.00
Induction of enzymes involed in the catabolism of deoxyribonucleosides and ribonucleosides in Escherichia coli K 12. Eur J Biochem (1971) 1.97
Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med (1998) 1.93
Mutations allowing growth on maltose of Escherichia coli K 12 strains with a deleted malT gene. Mol Gen Genet (1971) 1.92
Systematic review of the treatment and prognosis of the odontogenic keratocyst. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.85
Impact of internal mammary artery conduits on operative mortality in coronary revascularization. Ann Thorac Surg (1994) 1.85
Alcohol dehydrogenase-negative mutants in Drosophila: defects at the structural locus? Genetics (1976) 1.84
On the significance of the retention of ligand by protein. Proc Natl Acad Sci U S A (1975) 1.83
Energy-coupling of the transport system of Escherichia coli dependent on maltose-binding protein. Eur J Biochem (1977) 1.83
Reversible interaction between coliphage lambda and its receptor protein. J Mol Biol (1975) 1.82
Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat (1993) 1.79
Characterization and expression of the structural gene for pullulanase, a maltose-inducible secreted protein of Klebsiella pneumoniae. J Bacteriol (1985) 1.78
Restriction map of the Escherichia coli malA region and identification of the malT product. J Bacteriol (1980) 1.77
Fractures of the spine in diffuse idiopathic skeletal hyperostosis. Clin Orthop Relat Res (1991) 1.76
Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA (1991) 1.75
Occurrence of the bacteriophage lambda receptor in some enterobacteriaceae. J Virol (1975) 1.74
Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene. Hum Mutat (1997) 1.74
Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut (2005) 1.72
Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Biochem Mol Med (1996) 1.72
Characterization of Erwinia chrysanthemi extracellular proteases: cloning and expression of the protease genes in Escherichia coli. J Bacteriol (1987) 1.71
Magnetic resonance image-directed stereotactic neurosurgery: use of image fusion with computerized tomography to enhance spatial accuracy. J Neurosurg (1995) 1.70
The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet (1998) 1.67
Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol (1977) 1.66
Protective autoimmunity is a physiological response to CNS trauma. J Neurosci (2001) 1.64
Understanding physicians' intentions to withdraw from practice: the role of job satisfaction, job stress, mental and physical health. Health Care Manage Rev (2001) 1.63
Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci (2000) 1.62
Uridine phosphorylase from Escherichia coli. Physical and chemical characterization. Eur J Biochem (1977) 1.61
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A (2000) 1.61
Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci U S A (2001) 1.61
Inflammation after axonal injury has conflicting consequences for recovery of function: rescue of spared axons is impaired but regeneration is supported. J Neuroimmunol (1994) 1.60
Bicalutamide for advanced prostate cancer: the natural versus treated history of disease. J Clin Oncol (1997) 1.60
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
The effect of nalidixic acid on the expression of some genes in Escherichia coli K-12. Biochem Biophys Res Commun (1975) 1.59
Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6. Lab Invest (1991) 1.56
Essential and nonessential sequences in malPp, a positively controlled promoter in Escherichia coli. J Bacteriol (1985) 1.54
Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer (1999) 1.52
Interaction of the lamB protein with the peptidoglycan layer in Escherichia coli K12. Eur J Biochem (1980) 1.50
Catabolite repression in Escherichia coli mutants lacking cyclic AMP. Mol Gen Genet (1978) 1.50
Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study. J Rheumatol (2000) 1.50
Liposomal prostaglandin E1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial. Crit Care Med (1996) 1.48
Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia). Hum Mutat (2000) 1.48
Genetic heterogeneity among blue-cone monochromats. Am J Hum Genet (1993) 1.47
Identification of human plasma cholinesterase variants using molecular biological techniques. Acta Anaesthesiol Scand (1995) 1.47
RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest Ophthalmol Vis Sci (2000) 1.46
Nonsense mutations in the maltose A region of the genetic map of Escherichia coli. J Bacteriol (1969) 1.45
Physical fine mapping of the choroideremia locus using Xq21 deletions associated with complex syndromes. Genomics (1989) 1.44
Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology. Am J Clin Pathol (1995) 1.43
Quantitative CT analysis of brain morphometry in adult Down's syndrome at different ages. Neurology (1987) 1.43
Naturally conceived twins with monochorionic placentation have the highest risk of fetal loss. Ultrasound Obstet Gynecol (2006) 1.42
Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations. Hum Mutat (1998) 1.42
Increased serum cytokines and intercellular adhesion molecule-1 in fulminant Rocky Mountain spotted fever. Crit Care Med (1995) 1.41
The effect of relaxin on calcium fluxes in the rat uterus. Am J Obstet Gynecol (1988) 1.41
Mechanism of colicin E3 production in strains harboring wild-type or mutant plasmids. J Bacteriol (1978) 1.39
Improving fluid compliance in the hemodialysis population. Nephrol News Issues (1999) 1.38
Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators. J Neurochem (2005) 1.37